Small K M, Forbes S L, Rahman F F, Liggett S B
Departments of Medicine and Pharmacology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0564, USA.
Biochemistry. 2000 Mar 14;39(10):2815-21. doi: 10.1021/bi992497z.
The forward and antegrade interactions that comprise the agonist receptor-G protein complex were studied in Chinese hamster fibroblasts transfected to express the beta(2)-adrenergic receptor (beta(2)AR), the beta(2)AR and the alpha-subunit of its cognate G protein (G(s)), and a protein consisting of the beta(2)AR fused at its carboxy terminus with G(alpha)(s) (beta(2)AR-G(s)). Expression levels were matched at approximately 600 fmol/mg. Basal adenylyl cyclase activities were increased with the fusion receptor membranes compared to coexpressed receptor plus G(alpha)(s), and to wild-type beta(2)AR (20.5 +/- 1.8 vs 9.0 +/- 0.88 vs 8.7 +/- 0.93 pmol min(-)(1) mg(-)(1)), confirming in mammalian cells that the fusion of beta(2)AR and G(alpha)(s) results in a state not attained by expression of unfused components. However, agonist-stimulated activities were not increased proportionally, such that the stimulation over basal of the beta(2)AR-G(s) fusion protein (1. 5-fold) was less than wild-type beta(2)AR (2.1-fold). Agonist competition studies performed in the absence of guanine nucleotide exhibited high-affinity binding sites with a lower K(H) (1.75 vs 8. 47 nM) and greater %R(H) (51% vs 44%) for beta(2)AR-G(s), but GppNHp failed to convert most of these to the low-affinity state. Functional studies with the inverse agonist ICI 118551 did not show enhanced efficacy or potency with the fusion protein. Adenylyl cyclase studies with three partial agonists with diverse structures (dobutamine, ritodrine, and phenylephrine) showed no enhancement of efficacy with beta(2)AR-G(s) and a minor trend toward enhanced potency. Taken together, these results indicate that the tethering of G(alpha)(s) to the beta(2)AR causes a conformational change in the receptor that stabilizes a species "trapped" between the non-guanine nucleotide-bound state and the GTP-bound form. Functionally the receptor is not characterized by a consistent pattern of properties ascribed to other states such as constitutive activation or precoupling, but rather represents a unique state in the transition from high- to low-affinity forms.
在中国仓鼠成纤维细胞中研究了构成激动剂受体 - G蛋白复合物的正向和顺向相互作用,这些细胞被转染以表达β₂ - 肾上腺素能受体(β₂AR)、β₂AR及其同源G蛋白(Gₛ)的α亚基,以及一种在其羧基末端与Gαₛ融合的蛋白质(β₂AR - Gₛ)。表达水平在约600 fmol/mg处匹配。与共表达的受体加Gαₛ以及野生型β₂AR相比,融合受体膜的基础腺苷酸环化酶活性增加(20.5±1.8对9.0±0.88对8.7±0.93 pmol min⁻¹mg⁻¹),这在哺乳动物细胞中证实了β₂AR和Gαₛ的融合导致了未融合成分表达所无法达到的状态。然而,激动剂刺激的活性并未成比例增加,使得β₂AR - Gₛ融合蛋白的基础刺激倍数(1.5倍)小于野生型β₂AR(2.1倍)。在不存在鸟嘌呤核苷酸的情况下进行的激动剂竞争研究显示,β₂AR - Gₛ具有高亲和力结合位点,其K(H)较低(1.75对8.47 nM)且%R(H)较高(51%对44%),但GppNHp未能将大多数这些位点转化为低亲和力状态。用反向激动剂ICI 118551进行的功能研究未显示融合蛋白的效能或效力增强。用三种结构不同的部分激动剂(多巴酚丁胺、利托君和去氧肾上腺素)进行的腺苷酸环化酶研究表明,β₂AR - Gₛ的效能没有增强,效力有轻微增强趋势。综上所述,这些结果表明Gαₛ与β₂AR的连接导致受体构象变化,使一种“被困”在非鸟嘌呤核苷酸结合状态和GTP结合形式之间的物种稳定下来。在功能上,该受体并不具有归因于其他状态(如组成性激活或预偶联)的一致特性模式,而是代表了从高亲和力形式向低亲和力形式转变中的一种独特状态。